CORC

浏览/检索结果: 共196条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer 会议论文
作者:  Mamounas, Eleftherios P.;  Geyer, Charles E., Jr.;  Huang, Chiun-Sheng;  Mano, Max S.;  Loibl, Sibylle
收藏  |  浏览/下载:21/0  |  提交时间:2019/12/05
Phase III Randomized AUGMENT Study of Lenalidomide/Rituximab vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma 会议论文
作者:  Gribben, J.;  Trneny, M.;  Izutsu, K.;  Fowler, N. H.;  Hong, X.
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/05
Phase III study of trastuzumab emtansine (T-DM1) vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy including trastuzumab: Primary results from KATHERINE 会议论文
作者:  Geyer, C. E., Jr.;  Huang, C-S;  Mano, M. S.;  Loibl, S.;  Mamounas, E. P.
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
The treatment of acral vitiligo with autologous cultured epidermal grafts 会议论文
作者:  Chen, S.;  Li, J.;  Zhu, Q.;  Yang, K.;  Tang, L.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
OLAPARIB MAINTENANCE MONOTHERAPY IMPROVES PROGRESSION-FREE SURVIVAL (PFS) IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSROC): SOLO2 STUDY - CHINA COHORT 会议论文
作者:  Liu, J.;  Yin, R.;  Wu, L.;  Zhu, J.;  Lou, G.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Hu, Y.;  Liu, Z.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace